Facebook
Twitter
LinkedIn
ForwardMayo Clinic Cardio-Oncology Update 2024 Live (in-person)
This course offers Live (in-person) and Livestream (virtual) attendance options.
Chadi Ayoub, M.B.B.S., Ph.D., Joerg Herrmann, M.D., Carolyn M. Larsen, M.D., Lida A. Mina, M.D., Donald W. Northfelt, M.D., and Chris Ray, M.D.
November 7 - 9, 2024 - Fairmont Scottsdale Princess - Scottsdale, Arizona
This course reviews the prevention, diagnosis, and management of cardiac and vascular diseases of cancer patients throughout the continuum of their care including heart failure, myocardial ischemia, hypertension, thromboembolism, and arrhythmia. The course is directed towards the spectrum of providers who care for cancer patients to enable them to recognize the cardiovascular risk of their patients and take action to minimize this risk. This includes physicians, advance practice providers, pharmacists, and nurses in cardiology, hematology-oncology, primary care, and hospital internal medicine. The course includes lectures from experts as well as interactive case-based and question and answer sessions.
| Registration Fees | Early Bird (On or before October, 7, 2024) | Full Price (After October 7, 2024) | Livestream |
|---|---|---|---|
| M.D., D.O., Ph.D. | $950 | $1,025 | $950 |
| Allied Health, NP, PA, Retirees | $850 | $925 | $850 |
| Resident/Fellow | $550 | $550 | $250 |
| IC-OS Board Review | $150 | $150 | $150 |
*NEW* IC-OS Board Review Sessions. During the optional sessions, IC-OS members will review board style questions with participants. Participation in all board review sessions will offer 3.00 additional credit hours and requires separate registration. The target audience is attendees who are considering registering for the IC-OS Cardio-Oncology Board Certification Exam (https://ic-os.org/board-certification-admin/) or any attendees who are interested in additional cardio-oncology education in a question and answer format.
The objectives of the board review sessions are to:
- Solidify knowledge gained throughout the course by reviewing board style questions and answers with cardio-oncology experts
- Help prepare participants for the IC-OS Cardio-Oncology Board Certification certificate exam
Target Audience
This course is designed for general cardiologists, heart failure specialists, and advanced practice providers working in cardiology who either currently practice cardio-oncology or aim to expand their practice into the field to optimize the care of this patient population. The course is also designed for providers in hematology, oncology, and internal medicine as they are often the first to encounter and diagnose patients with cardiotoxicity related to cancer therapies.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Develop an approach to the prevention and management of cancer therapeutics related cardiotoxicity.
- Summarize guideline based cardiovascular surveillance during cancer therapy associated with a risk of cardiovascular toxicity.
- Identify an approach to the integration of multimodality imaging into the cardio-oncology practice.
- Review advances in the management of TTR and AL cardiac amyloidosis.
- Identify key diagnostic modalities for early detection of cardiac toxicity in cancer patients.
- Review current therapeutic interventions for carcinoid valvular heart disease.
- Assess the cardiovascular risk profile of individuals diagnosed with prostate cancer.
- Recognize unique risk factors for hypertension in cancer patients, including treatment-related factors and comorbidities.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge, or performance of any care or procedure(s) which may be discussed or taught in this course.
Mayo Clinic Cardio-Oncology Update 2024 |
Scottsdale, Arizona |
November 7, 2024 to November 9, 2024 |
Mountain Standard Time |
Day 1 | Thursday, November 7, 2024 |
6:45 AM | Registration, Continental Breakfast & Exhibits |
7:45 AM | Welcome and Announcements |
Session 1: Introduction to Cancer Therapy Related Cardiotoxicity | |
8:00 AM | Traditional Cancer Therapies |
8:30 AM | Targeted Therapies for Breast Cancer |
9:00 AM | Tyrosine Kinase Inhibitors |
9:30 AM | Break |
10:00 AM | Cellular Therapies and the Heart (CAR-T) |
10:30 AM | Checkpoint Inhibitors |
11:00 AM | Introduction to Radiation Therapy |
11:30 AM | Q&A Panel |
12:00 PM | Lunch Break - Ask a Pharmacist Session |
Session 2: Introduction to Cardio-Oncology | |
1:00 PM | Guideline Based Surveillance Strategy for Chemotherapy Related Cardiotoxicity: LVEF and Beyond |
1:30 PM | Prevention and Management of Chemotherapy Related Cardiotoxicity |
2:00 PM | Role for Advanced Heart Failure Therapies in Cardio-Oncology |
2:30 PM | Break |
3:00 PM | Role of Advanced Imaging in Cardio-Oncology |
3:30 PM | Artificial Intelligence: The Future of Risk Stratification and Early Detection of Cardiotoxicity? |
4:00 PM | Q&A Panel |
4:30 PM | Break |
4:45 PM | ICOS Board Review Questions |
6:15 PM | Adjourn |
Day 2 | Friday, November 8, 2024 |
6:30 AM | Continental Breakfast and Exhibits |
7:25 AM | Announcements |
7:30 AM | Keynote Lecture: Top 10 Publications in Cardio-Oncology in the Past Year |
Session 3: Leukemia and Lymphoma | |
8:30 AM | Stem Cell Transplant and the Heart |
9:00 AM | Understanding CHIP (Clonal Hematopoiesis of Indeterminate Potential) and Implications for Cardiovascular Risk |
9:30 AM | Break |
10:00 AM | Case Presentation: Atrial Fibrillation and CLL |
10:30 AM | Evaluation and Management of Drug Related QTc Prolongation |
11:00 AM | Guideline Based Management of DVT and PE |
11:30 AM | Q&A Panel |
12:00 PM | Lunch - Challenging Audience Cases Session (12:15 - 1:00 PM) |
Session 4: Cardiac Risk of Hormone Therapy | |
1:00 PM | Prostate Cancer and Heart Disease |
1:30 PM | Hormone Therapy and Cardiac Risk in Breast Cancer |
2:00 PM | Exercise and Cardiac Rehab for Cancer Patients |
2:30 PM | Hypertension Management in Cancer Patients |
3:00 PM | Q&A Session |
3:30 PM | Break |
3:45 PM | ICOS Board Review Questions |
5:15 PM | Adjourn |
Day 3 | Saturday, November 9, 2024 |
6:40 AM | Continental Breakfast and Exhibits |
7:40 AM | Announcements |
Session 5: Building a Cardio-Oncology Practice | |
7:45 AM | My Experience Building a Cardio-Oncology Practice |
8:15 AM | Key Pearls from my Cardio-Oncology Practice: An APP Perspective |
8:45 AM | Cardiovascular Considerations in Cancer Survivorship |
9:15 AM | Break |
9:45 AM | Neuroendocrine Tumors |
10:15 AM | Carcinoid Valvular Heart Disease |
10:45 AM | Malignant Cardiac Masses |
11:15 AM | Diagnosis and Management of Pericarditis and Pericardial Effusions in Cancer Patients |
11:45 AM | Q&A Panel |
12:15 PM | Lunch - Challenging Audience Cases Session (12:30 - 1:15 PM) |
Session 6: Amyloidosis | |
1:15 PM | Introduction to Cardiac Amyloidosis |
1:45 PM | Novel Treatments for TTR Amyloid |
2:15 PM | Treatment of AL Amyloid with Cardiac Involvement |
2:45 PM | Challenging Case(s) in Cardiac Amyloid |
3:15 PM | Q&A Session |
3:45 PM | Adjourn |
ROOM RATES:
A limited block of guest rooms has been reserved at a special group rate of $389 (USD), per night, plus tax and a daily resort service charge of $25 for single (or $40 for double occupancy). To receive the special group rate, please identify yourself as a registrant of the Mayo Clinic Cardio-Oncology Update 2024 and make your reservation before the room block is filled or by the expiration date of October 14, 2024. You may reserve your room by calling the hotel directly at 1-800-344-4758.
Reservation Link
ADDITIONAL ROOM OCCUPANTS:
A charge of $30.00 per person, per night will be added to the folio for each guest over double occupancy. There will be no charge for children up to and including the age of 18 years who share the room with their parents.
Maximum occupancy per room: four (4).
All travel and lodging expenses are the sole responsibility of the individual registrant.
Chadi Ayoub, M.B.B.S., Ph.D.
Joerg Herrmann, M.D.
Carolyn M. Larsen, M.D.
Lida A. Mina, M.D.
Donald W. Northfelt, M.D.
Chris Ray, M.D.
Mayo Faculty
Luis S. Allen, M.B.B.S., Ph.D.
Reza Arsanjani, M.D.
Melanie C. Bois, M.D.
Angela Dispenzieri, M.D.
Hicham El Masry, M.D.
Regis I. Fernandes, M.D.
Martha Grogan, M.D.
Brian W. Hardaway, M.D.
Sandra M. Herrmann, M.D.
Sameet R. Keole, M.D.
Alyssa D. McPherson, APRN, D.N.P.
Javier L. Munoz, M.D., M.B.A.
Hema Narayanasamy, M.B.B.S.
Jeanne M. Palmer, M.D.
Naveen L. Pereira, M.D.
Julie L. Rosenthal, M.D.
Kathryn J. Ruddy, M.D.
Fadi E. Shamoun, M.D.
Parminder Singh, M.D.
Bassam B. Sonbol, M.D.
David E. Steidley, M.D.
Hector R. Villarraga, M.D.
Guest Faculty
Daniel Lenihan, MD, FACC, FESC, FIC-OS
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 19.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
| Day | Credit |
|---|---|
| Thursday | 6.50 |
| Friday | 6.50 |
| Saturday | 6.50 |
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 19.50 ACPE Knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity. UAN Number: TBD
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 19.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 19.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College of Physicians and Surgeons of Canada
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 19.50 ABIM
- 19.50 ACPE
- 19.50 AMA PRA Category 1 Credit™
- 19.50 ANCC
- 19.50 Attendance
Price
Please update your profile to let us know if you have dietary restrictions or access requirements.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.